Drug firm Zydus Cadila has said that it has introduced a new feature in the packaging of its critical drugs to help patients ensure that the product is not fake or counterfeited. The company said it has incorporated a new IT-enabled scratch code which shall be printed under a scratchable surface. "Counterfeit drugs can be harmful as they may not have the desired outcome and could also be life threatening in some cases," Cadila Healthcare Managing Director Sharvil Patel noted. Cadila Healthcare is the listed entity of the Ahmedabad-based Zydus Cadila group which employs nearly 25,000 people worldwide, including 1,400 scientists in R&D. Zydus Cadila Q4 net profit up 73% to ₹679 crCadila Healthcare Limited, reported a growth of 73% in net profit on a consolidated basis to ₹679 crore in the January-March quarter of the financial year 2020-21.

Source: Mint May 28, 2021 17:26 UTC